EMD Millipore, the Life Science division of Merck KGaA, has agreed to acquire Seattle-based Amnis Corp. Amnis designs, manufactures and markets high-speed cell imaging instrumentation used in flow cytometry applications in academic, biotech and pharmaceutical cell analysis and research. Amnis has 40 employees and had sales of $14 million in 2010. The transaction, subject to regulatory approvals, is expected to close 4Q11. Terms of the transaction were not disclosed. “Amnis’ technology will put ...